SSSiyuan Sun

Siyuan Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Siyuan Sun has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Jianguang Wang

    Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China

    2 shared publications
  • Can Liu

    Department of Biochemistry, School of Basic Medical Sciences, Wenzhou Medical University , Wenzhou

    1 shared publication
  • Chen Lv

    Hangzhou Simo Co., Ltd., Hangzhou, China

    1 shared publication
  • Chenglin Yang

    Department of Clinical Medicine, Qiushi Academy for Advanced Studies, Zhejiang University , Hangzhou

    1 shared publication
  • Chipeng Xiao

    Department of Biochemistry, School of Basic Medical Sciences, Wenzhou Medical University

    1 shared publication
  • Hanbin Jia

    Center of Craniofacial Orthodontics, Department of Oral and Cranio‐Maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology Shanghai China

    1 shared publication

Latest Publications

  • Open Access

    Single‐Cell Virtual Perturbation Screening Identifies STAT3 as a Key Regulator of Dentinogenesis

    by Yanfei Zhu, Hongyuan Xu, Zijian Zhang, Siyuan Sun, Zihan Huang, Xin Gao, Houwen Pan, Xiangru Huang, Yuanqi Liu, Xinyu Wang, et al.

    Dentine formation constitutes a physiological process precisely regulated by signal transduction modules governing odontoblast differentiation and mineralisation. First, by constructing a single‐cell transcriptional landscape of odontogenic tissue, we defined EFNB2+ mesenchymal cells as a primary progenitor cluster, marking the origin of the odontogenic lineage. Integrating CellRank‐based fate mapping and SCENIC‐based regulon specificity analysis, we identified signal transducer and activator of transcription 3 (STAT3) as a pivotal transcriptional regulator of the odontoblast lineage. Subsequently, in silico perturbations using CellOracle predicted that STAT3 ablation disrupted the developmental vector field, redirecting the fate of mesenchymal precursors away from the odontoblast lineage. To substantiate these bioinformatic predictions, functional validation using shRNA‐mediated silencing and pharmacological modulation demonstrated that STAT3 was essential for the proliferation and differentiation capacity of dental mesenchymal cells. Furthermore, we generated conditional knockout mice targeting Stat3 in Osterix ‐expressing odontoblast progenitors, which consequently exhibited significant dentine dysplasia. Mechanistically, RNA‐seq and chromatin immunoprecipitation (ChIP) assays revealed that STAT3 directly bound to the WNT2B promoter, transcriptionally activating the Wnt/β‐catenin signalling pathway in dental mesenchymal cells. Overexpression of WNT2B partially rescued the odontogenic defects induced by STAT3 inactivation. This ‘prediction to verification’ study establishes STAT3 as a critical regulator of dentinogenesis and provides potential therapeutic targets for the treatment of dentine developmental disorders and the advancement of dentine regeneration.


  • Top Cited Papers

    Glycine increased ferroptosis via SAM-mediated GPX4 promoter methylation in rheumatoid arthritis

    by Hanzhi Ling, Man Li, Chenglin Yang, Siyuan Sun, Wei Zhang, Lin Zhao, Nannan Xu, Jinhao Zhang, Yecheng Shen, Xu Zhang, et al.

    Objective: Over-proliferation of synovium is a key event of invasive pannus formation and cartilage damage in the progression of RA disease. At the same time, ferroptosis may play a pivotal role in maintaining the balance of proliferation and death of synovium. In this study, we firstly evaluated the ferroptosis level in RA fibroblast-like synoviocytes (FLS) and then explored the role of glycine in ferroptosis. Methods: Ferroptosis was evaluated in RA synovium and FLS. The therapeutic effect of glycine on RA was evaluated by clinical and histopathological score and cytokine level in a CIA mouse model. The influence of glycine on ferroptosis was evaluated by mitochondrial morphology observation and membrane potential assay in RA FLS. Methylase expression was detected to explore the mechanism behind the effect of glycine on glutathione peroxidase 4 (GPX4) methylation. Results: Compared with healthy controls, ferroptosis decreased in the RA synovium and FLS, with a decrease in Acyl Coenzyme A Synthetase Long Chain 4 (ACSL4) and an increase in Ferritin heavy chain 1 (FTH1), GPX4 and cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11). Although both oxidation and antioxidation levels of lipids were higher in RA FLS than in healthy controls, the increase in antioxidation was slightly higher than oxidation. RNA-seq and verification showed that glycine regulated the ferroptosis pathway through increase S-adenosylmethionine (SAM) concentration and decrease the expression of GPX4 and FTH1 by promoting SAM-mediated GPX4 promoter methylation and reducing FTH1 expression in RA FLS. Conclusions: In summary, we confirmed a decline in ferroptosis in RA and explored that glycine enhanced ferroptosis via SAM-mediated GPX4 promoter methylation and ferritin decrease.


  • TSP1 is the essential domain of SEMA5A involved in pannus formation in rheumatoid arthritis

    by Chipeng Xiao, Chen Lv, Siyuan Sun, Heping Zhao, Hanzhi Ling, Man Li, Yang Qin, Jinhao Zhang, Jianguang Wang, Xinyu Yang

    In this study, we explored the effect of semaphorin5A (SEMA5A) on RA pathogenesis and its specific TSP1 domain on pannus formation. The expression of SEMA5A was detected in the synovium, the fibroblast-like synoviocytes (FLSs) and the SF of RA patients and healthy controls (HCs) by real-time quantitative PCR (q-PCR), immunohistochemistry staining, western blot and ELISA. SEMA5A-mAb intervention was performed to appraise the severity of joints in the CIA model. Transcriptome sequencing and bioinformatics analysis in SEMA5A-transfected FLSs from HCs were performed to screen differentially expressed genes after SEMA5A overexpression. An MTT assay in RA-FLSs, a chicken embryo allantoic membrane experiment and a tube formation experiment were used to clarify the influence of SEMA5A on cell proliferation and angiogenesis. Furthermore, a rescue experiment verified the function of the TSP1 domain of SEMA5A in the progress of RA with Sema5a−/− CIA mice. The expression of SEMA5A increased in RA compared with that in HCs. Simultaneously, SEMA5A-mAbs significantly attenuated joint injury and the inflammatory response in CIA models. In addition, transcriptome sequencing and angiogenesis-related experiments verified the ability of SEMA5A to promote FLS proliferation and angiogenesis. Moreover, TSP1 was proved to be an essential domain in SEMA5A-induced angiogenesis in vitro. Additionally, rescue of TSP1-deleted SEMA5A failed to reduce the severity of arthritis in a CIA model constructed with Sema5a −/− mice. In summary, upregulation of SEMA5A was first confirmed in pathological lesions of RA patients. Furthermore, treatment with SEMA5A-mAbs attenuated the progress of RA in the CIA model. Moreover, TSP1 was indicated as the key domain of SEMA5A in the promotion of pannus formation in RA. Graphical Abstract